Compounds > pyridoxal phosphate-6-azophenyl-2',4'-disulfonic acid
Page last updated: 2024-11-03

pyridoxal phosphate-6-azophenyl-2',4'-disulfonic acid and DDD MPGNII

pyridoxal phosphate-6-azophenyl-2',4'-disulfonic acid has been researched along with DDD MPGNII in 1 studies

pyridoxal phosphate-6-azophenyl-2',4'-disulfonic acid: a novel antagonist that selectively blocks P2 purinoceptor receptors; a useful tool to study co-transmission in tissues when ATP and coexisting neurotransmitters act in concert
5'-phosphopyridoxal-6-azobenzene-2,4-disulfonic acid : An arenesulfonic acid that is pyridoxal 5'-phosphate carrying an additional 2,4-disulfophenylazo substituent at position 6.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Rost, S1
Daniel, C1
Schulze-Lohoff, E1
Bäumert, HG1
Lambrecht, G1
Hugo, C1

Other Studies

1 other study available for pyridoxal phosphate-6-azophenyl-2',4'-disulfonic acid and DDD MPGNII

ArticleYear
P2 receptor antagonist PPADS inhibits mesangial cell proliferation in experimental mesangial proliferative glomerulonephritis.
    Kidney international, 2002, Volume: 62, Issue:5

    Topics: Actins; Animals; Blood Platelets; Cell Division; Cells, Cultured; Extracellular Matrix; Gene Express

2002